Megan Rohkamp
Director of Financial Reporting
Replay available
Inspire Medical Systems, Inc. (INSP) Q4 2021 Earnings Call
Inspire Medical Systems, Inc. (NYSE: INSP) Q4 2021 earnings conference call, held 2022-02-08. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Tim Herbert
President and Chief Executive Officer
Rick Buchholz
Chief Financial Officer
Robbie Marcus
Analyst at J.P. Morgan
Danielle Intelsey
Analyst at SVB Lyric
Chris Pascal
Analyst at Guggenheim
Adam Mater
Analyst at Piper Sandler
Larry Beagleson
Analyst at Wells Fargo
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Inspire Medical Systems, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.049 -- 00:00:05.092 Good afternoon. My name is Chris, and I'll be your conference operator today. 00:00:05.092 -- 00:00:10.635 At this time, I would like to welcome everyone to the Inspire Medical Systems Q4 00:00:10.635 -- 00:00:12.716 and full year 2021 00:00:12.716 -- 00:00:17.719 conference call. All lines have been placed on mute to prevent background noise. 00:00:17.719 -- 00:00:21.381 After the speaker's remarks, there will be a question and answer session. 00:00:21.381 -- 00:00:26.804 Thank you. Megan Rohkamp, Director of Financial Reporting at Inspire, 00:00:26.804 -- 00:00:29.845 you may begin the conference. 00:00:30.342 -- 00:00:33.043 Thank you all for participating in today's call. 00:00:33.043 -- 00:00:37.904 Joining me are Tim Herbert, President and Chief Executive Officer, and Rick Buchholz, 00:00:37.904 -- 00:00:42.715 Chief Financial Officer. Earlier today, we released financial results for the three and 00:00:42.715 -- 00:00:45.756 12 months ended December 31, 2021. 00:00:46.226 -- 00:00:49.487 A copy of the press release is available on our website. 00:00:49.487 -- 00:00:53.188 On this call, management will make forward-looking statements within the meaning of the 00:00:53.188 -- 00:00:58.310 federal securities laws. All forward-looking statements, including without 00:00:58.310 -- 00:01:03.717 limitation, Those relating to our operations, financial results and financial condition, 00:01:03.717 -- 00:01:09.601 investments in our business, continued effects of the COVID-19 pandemic, full year 2022 00:01:09.601 -- 00:01:14.745 financial and operational outlook, and improvements in market access are based upon our 00:01:14.745 -- 00:01:17.727 current estimates and various assumptions. 00:01:17.727 -- 00:01:21.849 These statements inv...